Subscribe to our RSS Feed
"Levels of BPA in the human body are very low, indicating that BPA is not accumulated in the body and is rapidly eliminated."
World Health Organization (WHO), November 2010
"BPA is safe at the current levels occuring in food"
FDA website 2015
"[…] the scientific evidence at this time does not suggest that the very low levels of human exposure to BPA through the diet are unsafe."
US Food and Drug Administration (FDA), March 2012
"An adequate margin of safety exists for BPA at current levels of exposure from food contact uses, for infants and adults"
US Food and Drug Administration (FDA), January 2010
"… the ingestion of BPA via food does not present a risk to consumers"
Swiss Health Authority, June 2011
"Receipts containing BPA do not pose a risk to consumers or cashiers"
Danish EPA, June 2011
"BPA poses no health risk to consumers of any age group at current exposure levels"
EFSA press release January 2015
"BPA poses no health risk to consumers of any age group at current exposure levels"
EFSA press release January 2015

Bisphenol-A and Risk Assessment

The EU Risk Assessment on bisphenol A (BPA) concluded that BPA and BPA-based products are safe. EU Risk Assessments are one element in the EU's Existing Substances Regulation to evaluate and control risks of chemical substances, one of the pre-cursors to REACH. They are widely recognised as the world's most rigorous scientific assessment of a substance's safety in existence today.

In the Risk Assessment Report on BPA published in June 2008, the European Commission concluded that products made from BPA, such as polycarbonate plastic and epoxy resins, are safe for consumers and the environment when used as intended.

For the BPA Risk Assessment independent scientific experts from the EU Members States considered several hundreds of studies that appeared during recent years, among them both small exploratory studies that do not follow established protocols, as well as comprehensive, statistically-robust studies following accepted international protocols and standards, such as the Good Laboratory Practice Directive. Overall, the studies also covered all potentially affected age groups of consumers including babies and small children.

This BPA Risk Assessment conclusion is consistent with conclusions of the scientific assessments of other regulatory bodies including the U.S. Food and Drug Administration (FDA) and the Japanese Ministry of Health, Labour and Welfare.

The Risk Assessment was also the basis for the BPA dossier registration under REACH. The dossier is currently being re-evaluated by the European Chemicals Agency. 

More information